EGBN
Eagle Bancorp, Inc.
EGBN's outlook is improving despite an expensive valuation.
JPM
JPMorgan Chase & Co.
JPM has the edge over EGBN overall, supported by stronger valuation and stronger modeled upside.
EGBN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
EGBN's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like EGBN.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
EGBN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $9.58 | -72% |
| Fair | 9.3x | $13.05 | -62% |
| Expensive | 11x | $15.45 | -55% |
| Forward | 15x | $34.38 | — |
| Current | 24x | $34.38 | — |
Historical ranges are pointers, not guarantees.
EGBN's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over EGBN in the historical PE scenario, which offers more potential upside but is not a forecast.
EGBN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect EGBN's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
EGBN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.28 | +62% |
| Q3 2026 | $1.41 | +$5.36 |
| Q2 2026 | -$1.60 | -$0.59 |
| Q1 2026 | -$4.13 | -$2.64 |
| Q4 2025 | -$4.55 | -$2.99 |
| Q3 2025 | -$3.95 | -$2.56 |
| Q2 2025 | -$1.01 | +$0.19 |
| Q1 2025 | -$1.49 | -159% |
| Q4 2024 | -$1.56 | -147% |
EGBN has returned to profit: it earned $1.41 per share over the past year, after losing money the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over EGBN on earnings, with more consistent year-over-year improvement.
EGBN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $70.9M | +0.3% |
| Q2 2026 | $73.1M | -1.5% |
| Q1 2026 | $76.4M | +3.4% |
| Q4 2025 | $80.5M | +7.5% |
| Q3 2025 | $70.7M | -10% |
| Q2 2025 | $74.2M | -3.3% |
| Q1 2025 | $73.9M | -5.7% |
| Q4 2024 | $74.9M | -1.4% |
EGBN's revenue fell from its 2020 peak and has held roughly level since: $71M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +149 points |
| Q2 2026 | 10% | +158 points |
| Q1 2026 | 21% | +18 points |
| Q4 2025 | -6.2% | -33 points |
| Q3 2025 | -119% | -153 points |
| Q2 2025 | -147% | -44 points |
| Q1 2025 | 3.3% | -0.1 points |
| Q4 2024 | 26% | -6.4 points |
EGBN's operating margin was 30% last quarter, up 149 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over EGBN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over EGBN on profitability, with a higher operating margin.
EGBN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $54.2M | +242% |
| Q2 2026 | $31.5M | +$60.9M |
| Q1 2026 | $14.3M | -67% |
| Q3 2025 | $15.8M | -72% |
| Q2 2025 | -$29.3M | -153% |
| Q1 2025 | $43M | +1413% |
| Q3 2024 | $55.6M | +17% |
| Q2 2024 | $55.2M | +80% |
EGBN's free cash flow was $91M over the past year, up 7.2% from the year before. Free cash flow isn't a meaningful measure for financial services companies like EGBN.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
EGBN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +64K shares |
| 1 year | +0.9% | +266K shares |
| 3 years | +2.3% | +690K shares |
| 5 years | -4.4% | -1.4M shares |
| Available history | -10% | -3.6M shares |
EGBN has 31M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $2,000 |
| Q3 2023 | $2,000 |
| Q2 2023 | $29.7M |
| Q1 2023 | $18.4M |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over EGBN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
EGBN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q1 2024 | 16.2x | High |
| Q4 2023 | 0.7x | Very low |
| Q3 2023 | 0.4x | Very low |
| Q2 2023 | 0.4x | Very low |
| Q1 2023 | 0.4x | Very low |
| Q4 2022 | 5.5x | High |
| Q3 2022 | 0.2x | Very low |
EGBN's net debt is about 1.5 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like EGBN.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over EGBN on leverage, with a lower net debt burden relative to earnings.
EGBN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.5 | Overbought |
| Stochastic | 89.0 | Overbought |
EGBN's weekly RSI is 73 (overbought) and its Stochastic is 89 (overbought).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
EGBN PE vs Financial Services Sector
| Metric | EGBN | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 13x | 87% above |
| PE % | 100 | 63 | 37 pts above |
EGBN is trading at 24x earnings, a 87% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over EGBN on valuation relative to its sector.
EGBN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.1 | 11% above |
| 20 week MA | $29.2 | 18% above |
| 50 week MA | $26.8 | 28% above |
| 100 week MA | $23.5 | 46% above |
| 200 week MA | $24.5 | 40% above |
EGBN has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
EGBN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.8 | $41.0 | -16% |
| 2021 | $41.0 | $56.8 | +39% |
| 2022 | $56.8 | $44.6 | -21% |
| 2023 | $44.6 | $30.1 | -32% |
| 2024 | $30.1 | $26.0 | -14% |
| 2025 | $26.0 | $21.2 | -19% |
| 2026 YTD | $21.2 | $34.4 | +62% |
EGBN has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.